Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,760.00
(
-0.15%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.43
(
-2.02%
)
Bitcoin
70,438.33
(
-1.13%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: urche post# 129277

Monday, 10/24/2011 9:38:12 PM

Monday, October 24, 2011 9:38:12 PM

Post# of 257262

As if to preempt the Xarelto sNDA submission, Public Citizen is campaigning to stave off approval on grounds the ROCKET-AF study was seriously flawed. Although I have heard many of these criticisms, I wonder what is the motive or agenda of Public Citizen? Are they interested in costs, wanting to avoid expensive new drugs with marginal advantages?

Public Citizen does not corporations to make money by selling drugs. It’s really that simple.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now